Canada markets open in 6 hours 34 minutes

Aarti Drugs Limited (AARTIDRUGS.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
518.90+2.05 (+0.40%)
As of 12:25PM IST. Market open.
Currency in INR

Valuation Measures4

Market Cap (intraday) 47.52B
Enterprise Value 52.96B
Trailing P/E 27.85
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.88
Price/Book (mrq)3.71
Enterprise Value/Revenue 2.09
Enterprise Value/EBITDA 16.52

Trading Information

Stock Price History

Beta (5Y Monthly) 0.86
52-Week Change 312.27%
S&P500 52-Week Change 324.96%
52 Week High 3645.75
52 Week Low 3431.05
50-Day Moving Average 3496.01
200-Day Moving Average 3498.33

Share Statistics

Avg Vol (3 month) 3190.5k
Avg Vol (10 day) 3180.23k
Shares Outstanding 591.94M
Implied Shares Outstanding 691.94M
Float 833.67M
% Held by Insiders 161.94%
% Held by Institutions 16.48%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 41
Forward Annual Dividend Yield 40.19%
Trailing Annual Dividend Rate 31.00
Trailing Annual Dividend Yield 30.19%
5 Year Average Dividend Yield 42.33
Payout Ratio 45.39%
Dividend Date 3N/A
Ex-Dividend Date 4Feb 06, 2024
Last Split Factor 24:1
Last Split Date 3Sept 30, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 6.78%
Operating Margin (ttm)11.82%

Management Effectiveness

Return on Assets (ttm)6.93%
Return on Equity (ttm)13.87%

Income Statement

Revenue (ttm)25.29B
Revenue Per Share (ttm)275.02
Quarterly Revenue Growth (yoy)-16.50%
Gross Profit (ttm)N/A
EBITDA 3.2B
Net Income Avi to Common (ttm)1.71B
Diluted EPS (ttm)18.55
Quarterly Earnings Growth (yoy)-15.50%

Balance Sheet

Total Cash (mrq)207.7M
Total Cash Per Share (mrq)2.26
Total Debt (mrq)5.64B
Total Debt/Equity (mrq)44.02%
Current Ratio (mrq)1.66
Book Value Per Share (mrq)139.39

Cash Flow Statement

Operating Cash Flow (ttm)3.59B
Levered Free Cash Flow (ttm)1.22B